216Background: [18F]Fluciclovine PET is clinically approved for detection of biochemically recurrent prostate cancer (PCa). However, its use for initial staging and treatment monitoring remains unc... Click to show full abstract
216Background: [18F]Fluciclovine PET is clinically approved for detection of biochemically recurrent prostate cancer (PCa). However, its use for initial staging and treatment monitoring remains unc...
               
Click one of the above tabs to view related content.